FOLLOW US

  • facebook
  • twitter
Wed

March 11, 2026

AstraZeneca To Buy EsoBiotec

America March 17, 2025

AstraZeneca To Buy EsoBiotec in $1B Deal

British-Swedish pharmaceutical powerhouse AstraZeneca PLC has announced a landmark deal to acquire Belgian biotech firm EsoBiotec SA for up to…

By Rihem Akkouche

MaxCyte Buys SeQure Dx For Up To $7M

America January 30, 2025

MaxCyte Buys SeQure Dx for Up to $7M

MaxCyte Inc., a leading cell therapy and gene editing company, announced Thursday that it has acquired SeQure Dx, a specialized…

By Rihem Akkouche

Kyverna Upsized $319M IPO

America February 8, 2024

Kyverna Upsized $319M IPO Signals Surge in Life Sciences Market

Cell therapy innovator, Kyverna Therapeutics Inc., embarks on a thrilling journey to debut in the trading arena after an electrifying…

By Rihem Akkouche

Signup for the USA Herald
exclusive Newsletter